Immunosuppressive Agents: all 5,940 studies that test it

Page 20 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus NephritisCompletedNCT00709722Phase 1/2Results posted
• Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCTCompletedNCT00709592Phase 2Results posted
• Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute RejectionCompletedNCT00707759Phase 3Results posted
• Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA SubjectsTerminatedNCT00706797Phase 4Results posted
• Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kgCompletedNCT00705367Phase 1Results posted
• Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® TherapyCompletedNCT00702052Phase 2Results posted
• Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid ArthritisCompletedNCT00695188Phase 4Results posted
• Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantCompletedNCT00691015Phase 2Results posted
• RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in EuropeCompletedNCT00688753Phase 2Results posted
• RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in EuropeCompletedNCT00688623Phase 2Results posted
• Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in JapanCompletedNCT00688103Phase 4Results posted
• Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host DiseaseCompletedNCT00686855Phase 2Results posted
• Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast CancerTerminatedNCT00679029Phase 2Results posted
• A Phase II Study of Umbilical Cord Blood TransplantationTerminatedNCT00676806Phase 2Results posted
• Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyCompletedNCT00674362Phase 3Results posted
• Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient ChemotherapyTerminatedNCT00673179Not applicableResults posted
• Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma MultiformeCompletedNCT00672243Phase 2Results posted
• Raptiva and Sirolimus in Islet Transplantation for Type 1 DiabetesTerminatedNCT00672204Phase 1/2Results posted
• Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic LeukemiaCompletedNCT00671658Phase 2Results posted
• An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple SclerosisCompletedNCT00670449Phase 2Results posted
• Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell LymphomaCompletedNCT00670358Phase 1/2Results posted
• Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/LymphomaCompletedNCT00669877Phase 2Results posted
• Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of MetabolismTerminatedNCT00668564Phase 2Results posted
• Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by SurgeryTerminatedNCT00665457Phase 2Results posted
• Phase IIIB Switching From Intravenous to Subcutaneous StudyCompletedNCT00663702Phase 3Results posted
• Study Evaluating Etanercept for the Treatment of Moderate to Severe PsoriasisCompletedNCT00663052Phase 4Results posted
• Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisCompletedNCT00662649Phase 3Results posted
• Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and CorticosteroidsCompletedNCT00658320Phase 3Results posted
• CAMEO: Canadian Methotrexate and Etanercept Outcome StudyCompletedNCT00654368Phase 4Results posted
• Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return VisitCompletedNCT00654355Phase 4Results posted
• Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous SystemCompletedNCT00653068Phase 3Results posted
• Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)TerminatedNCT00651482Phase 2Results posted
• Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DMCompletedNCT00651040Phase 3Results posted
• CLARITY Extension StudyCompletedNCT00641537Phase 3Results posted
• Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerTerminatedNCT00640978Phase 2Results posted
• Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell TransplantCompletedNCT00639717Phase 2Results posted
• Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With AvastinCompletedNCT00635050Phase 2Results posted
• Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple MyelomaTerminatedNCT00635024Phase 2Results posted
• Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant RecipientsCompletedNCT00634920Phase 4Results posted
• Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without VoraxazeCompletedNCT00634504Phase 1Results posted
• A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform NeurofibromasCompletedNCT00634270Phase 2Results posted
• Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00634244Phase 2Results posted
• A Phase I/II Trial of VR-CHOP in Lymphoma PatientsCompletedNCT00634179Phase 1/2Results posted
• RAD001 and Bicalutamide for Androgen Independent Prostate CancerCompletedNCT00630344Phase 2Results posted
• Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi AnemiaCompletedNCT00630253Phase 1/2Results posted
• Busulfan, Melphalan, and Fludarabine With Peri-transplant Palifermin, Followed by a T-Cell Depleted Hematopoietic Stem Cell Transplant From HLA Matched or Mismatched Related or Unrelated Donors in Patients With Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)CompletedNCT00629798Phase 2Results posted
• RAD001 in Patients With Metastatic, Hormone-Refractory Prostate CancerCompletedNCT00629525Phase 2Results posted
• Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast CancerCompletedNCT00629499Phase 2Results posted
• Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney TransplantationCompletedNCT00629122Phase 4Results posted
• Rapamycin for Prevention of Chronic Graft-Versus-Host DiseaseTerminatedNCT00623012Phase 1/2Results posted
• Allogeneic Hematopoietic Cell Transplantation for Severe Systemic SclerosisCompletedNCT00622895Phase 1/2Results posted
• Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant RecipientsCompletedNCT00622869Phase 3Results posted
• Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple SclerosisCompletedNCT00622700Phase 3Results posted
• Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic CancersCompletedNCT00619645Phase 2Results posted
• Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of TumorsCompletedNCT00618813Not applicableResults posted
• Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell HistiocytosisTerminatedNCT00618540Phase 2Results posted
• Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast CancerTerminatedNCT00616122Phase 1/2Results posted
• Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast CancerCompletedNCT00615901Not applicableResults posted
• Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerCompletedNCT00611351Phase 2Results posted
• Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00609167Phase 2Results posted
• LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune HepatitisTerminatedNCT00608894Phase 2Results posted
• Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilTerminatedNCT00608517Not applicableResults posted
• Pharmacokinetics of LCP-Tacro in Stable Liver Transplant PatientsCompletedNCT00608244Phase 2Results posted
• Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine CarcinomaCompletedNCT00607113Phase 2Results posted
• Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine TumorsCompletedNCT00605566Phase 2Results posted
• Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCompletedNCT00602836Phase 2Results posted
• Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic LeukemiaCompletedNCT00602459Phase 2Results posted
• Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung CancerCompletedNCT00601796Phase 2Results posted
• Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With ThalidomideCompletedNCT00600028Phase 3Results posted
• A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological MalignancyCompletedNCT00597519Phase 2Results posted
• Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + EverolimusCompletedNCT00597506Phase 2Results posted
• Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and FludarabineCompletedNCT00595127Not applicableResults posted
• Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System LymphomaCompletedNCT00594815Not applicableResults posted
• Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic TransplantationTerminatedNCT00593645Phase 2Results posted
• RAD001 Plus Bevacizumab in Metastatic MelanomaCompletedNCT00591734Phase 2Results posted
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic SyndromeTerminatedNCT00589316Phase 1Results posted
• Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCHCompletedNCT00588536Phase 2Results posted
• Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed OsteosarcomaCompletedNCT00586846Phase 2Results posted
• Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or FeetCompletedNCT00585650Phase 1/2Results posted
• A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01TerminatedNCT00583557Phase 2Results posted
• A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02CompletedNCT00583362Phase 2Results posted
• Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral InfectionTerminatedNCT00582738Phase 2Results posted
• Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin TherapyCompletedNCT00581555Phase 4Results posted
• Effects of Etanercept on Nail Psoriasis and Plaque PsoriasisCompletedNCT00581100Phase 4Results posted
• Dosing Flexibility Study in Patients With Rheumatoid ArthritisCompletedNCT00580840Phase 4Results posted
• UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple MyelomaCompletedNCT00580372Phase 2Results posted
• Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid ArthritisCompletedNCT00579878Phase 3Results posted
• Phase I/II Thymus Transplantation With Immunosuppression #950CompletedNCT00579527Phase 1/2Results posted
• Allogeneic Stem Cell Transplant for Patients With Severe Aplastic AnemiaTerminatedNCT00578903Phase 2Results posted
• Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous DiseaseCompletedNCT00578643Phase 2Results posted
• T-Reg Cell Kinetics, Stem Cell Transplant, REGALETerminatedNCT00578539Not applicableResults posted
• T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINETerminatedNCT00578461Not applicableResults posted
• Belatacept Pharmacokinetic Trial in Renal TransplantationCompletedNCT00578448Phase 2Results posted
• Bone Marrow Transplantation, Hemoglobinopathies, SCALLOPTerminatedNCT00578344Not applicableResults posted
• Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLOTerminatedNCT00578292Not applicableResults posted
• Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma PatientsCompletedNCT00577993Phase 3Results posted
• Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins LymphomaCompletedNCT00577629Phase 2Results posted
• A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and MelphalanCompletedNCT00577278Phase 2Results posted
• Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast CancerCompletedNCT00577122Phase 2Results posted
• Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaCompletedNCT00576979Phase 1/2Results posted

← Immunosuppressive Agents overview